FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/093008 [Registered on: 13/08/2025] Trial Registered Prospectively
Last Modified On: 12/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Probiotic
Other (Specify) [Oral Prophylaxis]  
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   A clinical and microbiological randomized trial to compare the effect of oral probiotics on bad breath in diabetic patients, with and without periodontitis 
Scientific Title of Study   A comparative study to evaluate and assess the efficacy of oral probiotics on oral halitosis in uncontrolled diabetics with and without periodontitis: a clinico- microbiological randomized controlled trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Mac Fonseca 
Designation  Post Graduate Student 
Affiliation  Goa Dental College and Hospital 
Address  40,Fonseca house,Luis de Menezes road Panaji Goa
Goa Dental College And Hospital, Department Number 2, Department of Periodontics, Bambolim, Goa North Goa GOA 403202
North Goa
GOA
403001
India 
Phone  8975249860  
Fax    
Email  scorpian5mac@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Mac Fonseca 
Designation  Post Graduate Student 
Affiliation  Goa Dental College and Hospital 
Address  40,Fonseca house,Luis de Menezes road Panaji Goa
Goa Dental College And Hospital, Department Number 2, Department of Periodontics, Bambolim, Goa North Goa GOA 403202
North Goa
GOA
403001
India 
Phone  8975249860  
Fax    
Email  scorpian5mac@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr James Samuel 
Designation  Professor and Head of Department 
Affiliation  Goa Dental College and Hospital 
Address  Bambolim, Goa North Goa GOA 403202
Goa Dental College And Hospital, Department Number 2, Department of Periodontics, Bambolim, Goa North Goa GOA 403202
North Goa
GOA
403202
India 
Phone  8975249860  
Fax    
Email  jamessamueldental@gmail.com  
 
Source of Monetary or Material Support  
Goa Dental College And Hospital, Bambolim, Goa North Goa GOA 403202 INDIA 
 
Primary Sponsor  
Name  Mac Fonseca 
Address  Goa Dental College And Hospital, Department Number 2, Department Of Periodontics, Bambolim, Goa India 403202 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Mac Fonseca  Goa Dental College And Hospital  Department Number 2, Department of Periodontics, Bambolim, Goa North Goa GOA
North Goa
GOA 
8975249860

scorpian5mac@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Goa Dental College And Hospital Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K053||Chronic periodontitis, (2) ICD-10 Condition: R196||Halitosis, (3) ICD-10 Condition: E119||Type 2 diabetes mellitus without complications,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Diabetic Patients(HbA1c 8%) who have Oral Halitosis with Periodontitis and treated with Oral Prophylaxis alone  Blood investigations to evaluate the glycated haemoglobin.Subjective as well as Objective halitosis will be evaluated using the hand held portable Halimeter. Patients in this group will undergo oral prophylaxis at baseline and Plaque sample will be taken for microbiological evaluation of P gingivalis(Causative agent for Oral Halitosis).Periodontal parameters like Pocket probing depth (PPD) ), Clinical Attachment Level (CAL) Gingival index (Loe and Silness 1963), Plaque index (Silness and Loe 1964), Sulcus bleeding index (Muhlemann and Son, 1971) and Oral Health Related Quality of life Index(OhRQOL) will be recorded for each patient at baseline and after 3 months .HbA1c will be evaluated again after three months along with the microbiological sample of the plaque for P gingivalis 
Intervention  Diabetic Patients(HbA1c 8%) who have Oral Halitosis with Periodontitis and treated with Oral Prophylaxis and a chewable Oral Probiotic  Blood investigations to evaluate the glycated haemoglobin.Subjective as well as Objective halitosis will be evaluated using the hand held portable Halimeter. Patients in this group will undergo oral prophylaxis at baseline and Plaque sample will be taken for microbiological evaluation of P gingivalis(Causative agent for Oral Halitosis).Periodontal parameters like Pocket probing depth (PPD) ), Clinical Attachment Level (CAL) Gingival index (Loe and Silness 1963), Plaque index (Silness and Loe 1964), Sulcus bleeding index (Muhlemann and Son, 1971) and Oral Health Related Quality of life Index(OhRQOL) will be recorded for each patient at baseline and after 3 months. Oral probiotic will be prescribed one tablet containing Streptococcus Thermophiles per day for one month and the HbA1c will be evaluated again after three months along with the microbiological sample of the plaque for P gingivalis 
Comparator Agent  Diabetic Patients(HbA1c 8%) who have Oral Halitosis without Periodontitis and treated with Oral Prophylaxis alone  Blood investigations to evaluate the glycated haemoglobin.Subjective as well as Objective halitosis will be evaluated using the hand held portable Halimeter. Patients in this group will undergo oral prophylaxis at baseline and Plaque sample will be taken for microbiological evaluation of P gingivalis(Causative agent for Oral Halitosis).Periodontal parameters like Pocket probing depth (PPD) ), Clinical Attachment Level (CAL) Gingival index (Loe and Silness 1963), Plaque index (Silness and Loe 1964), Sulcus bleeding index (Muhlemann and Son, 1971) and Oral Health Related Quality of life Index(OhRQOL) will be recorded for each patient at baseline and after 3 months .HbA1c will be evaluated again after three months along with the microbiological sample of the plaque for P gingivalis 
Intervention  Diabetic Patients(HbA1c 8%) who have Oral Halitosis without Periodontitis and treated with Oral Prophylaxis and a chewable Oral probiotic  Blood investigations to evaluate the glycated haemoglobin.Subjective as well as Objective halitosis will be evaluated using the hand held portable Halimeter. Patients in this group will undergo oral prophylaxis at baseline and Plaque sample will be taken for microbiological evaluation of P gingivalis(Causative agent for Oral Halitosis). Periodontal parameters like Pocket probing depth (PPD) ), Clinical Attachment Level (CAL) Gingival index (Loe and Silness 1963), Plaque index (Silness and Loe 1964), Sulcus bleeding index (Muhlemann and Son, 1971) and Oral Health Related Quality of life Index(OhRQOL) will be recorded for each patient at baseline and after 3 months . Oral probiotic will be prescribed one tablet containing Streptococcus Thermophiles per day for one month and the HbA1c will be evaluated again after three months along with the microbiological sample of the plaque for P gingivalis 
 
Inclusion Criteria  
Age From  35.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Confirmed diagnosis of type 2 Diabetes mellitus
Clinically perceptible halitosis
Atleast 20 teeth present
Localised or Generalised periodontitis in group 
 
ExclusionCriteria 
Details  Patients taking any other medications
Patients with known allergies or hypersensitivity reactions
Pregnant and lactating women
Subjects who underwent periodontal treatment within a period of 6 months
H/O antibiotic intake at least 3 months prior
H/O use of mouthwashes within 4 weeks before the start of the study
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Other 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Improvement of Oral Halitosis  Baseline, 1 month and 3 months 
 
Secondary Outcome  
Outcome  TimePoints 
Change in Microbiological assay(P gingivalis)
 
Baseline and 3 months 
Reduction in HbA1c  Baseline and 3 months 
Reduction in Plaque index  Baseline and 3 months 
Reduction in gingival index  Baseline and 3 months 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   01/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The study is a randomised controlled trial to evaluate the clinical effect of Oral Probiotics as an adjunct to scaling and root planing(SRP) in the treatment of Oral Halitosis in Diabetic patients with and without Periodontitis
The Objectives of the study are
1)To evaluate the clinical effect of Oral Probiotic as an adjunct therapy to SRP on Oral Halitosis in
a)Diabetic patients without Periodontitis
b)Diabetic patients with Periodontitis
2)To evaluate the clinical effect of SRP on microbiological parameters of P. gingivalis in plaque samples at baseline and in six weeks                           
3)To evaluate the clinical effect of only SRP on Oral Halitosis in

      a)Diabetic patients without Periodontitis
      b)Diabetic patients with Periodontitis
IV. To evaluate the effect of the intervention on the Glycated haemoglobin after 3 months
V.To compare the clinical parameters on test and control groups


 
Close